Compare Elastic NV (ESTC) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Elastic NV vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Elastic NV trades at $97.26 (market cap $10.00B), while Halozyme Therapeutics Inc. Common Stock trades at $112.27 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is the larger of the two by market cap, and Halozyme Therapeutics Inc. Common Stock is more actively traded (2,179,278 versus 1,610,337). Which is the better fit depends on your goals — on Pluang, investors hold Elastic NV for 10 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| ESTC | HALO | |
|---|---|---|
Market Cap | $10.00B | $12.58B |
Volume | 1,610,337 | 2,179,278 |
Sector | Technology | Health |
52-Week High | $99.91 | $115.22 |
52-Week Low | $43.30 | $61.63 |
Typical Hold Time | 10 Days | 1 Days |
Enterprise Value | $9.14B | $14.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Elastic (ESTC) trades at $96.44, up 3.59% today, with a bullish technical outlook and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Recent product launches in AI and observability platforms highlight innovation, while profitability metrics show improvement into 2026. The current price sits near resistance at $97, with RSI indicating potential overbought conditions short-term.
Outlook remains positive given earnings momentum and product expansion, but risks include high valuation multiples and insider selling. The consensus price target of $79.50 suggests caution, though bullish sentiment prevails with 65% buy ratings. Investors should weigh growth potential against execution risks in a competitive software market.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Elastic NV
Elastic NV provides a leading search AI platform built on Elasticsearch. Its software helps organizations find, observe, and protect data through search-powered analytics for various cloud-based applications.
Read more on ESTC →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
